Statistics on Biotechnology Use  
Results by sector of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

;Total Companies;Services;Industry and Construction;Agriculture;
No. of companies carrying out R&D in Biotechnology;1.078;695;298;85;
%Companies according to biotechnology used: Genetic code;35;43;16;38;
%Companies according to biotechnology used: Functional units;42;45;40;18;
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;27;30;18;29;
%Companies according to biotechnology used: Bioprocesses;49;41;72;32;
%Companies according to biotechnology used: Sub-cellular organisms;8;10;4;1;
%Companies according to biotechnology used: Bio-computing;22;30;6;7;
%Companies according to biotechnology used: Nanobiotechnology;14;18;7;1;
%Companies according to biotechnology used: Other;12;12;10;16;
Companies in which biotechnology activities are: Main and/or exclusive;526;448;71;7;
Companies in which biotechnology activities are: A secondary line of business;173;101;61;11;
Companies in which biotechnology activities are: A tool necessary for production;379;146;166;68;
%Company by field(s) of ultimate application of biotechnology use: Human Health;48;63;27;4;
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;20;20;16;33;
%Company by field(s) of ultimate application of biotechnology use: Food products;33;25;50;35;
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;24;21;19;60;
%Company by field(s) of ultimate application of biotechnology use: Environment;15;16;15;9;
%Company by field(s) of ultimate application of biotechnology use: Industry;14;16;10;1;
Personnel in R&D in biotechnology (no. of persons);10.191;6.743;2.733;715;
Personnel in R&D in biotechnology (no. of persons): Researchers;5.774;4.260;1.267;247;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;4.417;2.483;1.466;468;
Personnel in R&D in biotechnology (no. of persons): women;5.525;3.876;1.350;298;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;3.015;2.286;637;91;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;2.511;1.590;713;207;
Personnel in R&D in biotechnology (FTE);7.191,4;4.952,9;1.826,7;411,7;
Personnel in R&D in biotechnology (FTE): Researchers;4.276,6;3.198,6;917,6;160,4;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;2.914,7;1.754,3;909,1;251,3;
Personnel in R&D in biotechnology (FTE): women;3.985,4;2.831,9;953,7;199,8;
Personnel in R&D in biotechnology (FTE): (women) Researchers;2.234;1.696,3;475,9;61,8;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;1.751,4;1.135,6;477,9;137,9;
Internal expenditure on R&D (thousands of euros);578.171;395.589;159.179;23.403;
1) By nature of the expense: Current expenses;517.601;349.562;146.112;21.927;
1.1) Remuneration to researchers;213.755;151.067;55.410;7.278;
1.2) Remuneration to technicians and assistants;98.440;55.120;36.579;6.741;
1.3) Other current expenses;205.406;143.375;54.123;7.908;
2) By nature of the expense: Capital expenses;60.570;46.027;13.067;1.476;
2.1) Land and buildings;22.609;21.356;1.165;87;
2.2) Equipment and instruments;36.169;22.930;11.860;1.379;
2.3) Acquisition of specific R&D software;1.793;1.741;42;10;
1) By origin of the funds: National funds;487.615;340.944;125.565;21.105;
1.1) Own funds;330.459;193.495;117.264;19.701;
1.2) From companies;45.462;42.794;2.668;.;
1.3) Public Administration funds;66.189;59.179;5.605;1.405;
1.4) From Universities;25.148;25.119;29;.;
1.5) From non profit private institutions;20.357;20.357;.;.;
1) By origin of the funds: Foreign funds;90.556;54.645;33.614;2.298;
2.1) From EU programmes;20.932;20.111;802;20;
2.2) Other foreign funds;69.624;34.534;32.812;2.278;
Purchase of R&D services in biotechnology (thousands of euros);166.022;90.846;73.316;1.860;
Purchase of R&D services in biotechnology (thousands of euros): In Spain;97.455;49.037;47.171;1.247;
Purchase of R&D services in biotechnology (thousands of euros): Abroad;68.567;41.809;26.144;614;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;46;54;32;31;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;13;12;17;14;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;14;14;15;12;
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;14;16;11;7;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;17;20;12;14;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;17;20;11;11;
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;18;18;17;20;
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;35;36;36;28;
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;49;51;43;51;
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;21;22;19;19;
% Companies that have requested biotechnology patents in Biotechnology;15;19;10;5;
Number of patents requested;526;390;99;37;
% Companies with income of an international origin related to biotechnological activities;26;27;25,7;18,9;
% Turnover representing income of an international origin related to biotechnological activities;1,4;6,6;1,1;1,3;
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;63,8;44,1;72,2;67;
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;36,2;55,9;27,8;33;
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;91,6;76,6;98,5;77,6;
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;0,9;0,5;0,4;22,4;
% Income of an international origin related with activities according to the classification: Operating source abroad;1,9;5,7;0,3;.;
% Income of an international origin related with activities according to the classification: Other;5,6;17,2;0,8;.;
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute